GPT and metabolic dysfunction-associated steatotic liver disease: Three I. obliquus constituents, including inotodiol (17), lanosterol (18), and trametenolic acid (21) also possess protective activity against non-alcoholic fatty liver disease (NAFLD) by exerting anti-lipid deposition effects, reversal of liver weight loss, reduction of liver triglyceride content, and restoration of dysregulated alanine transaminase (ALT) and aspartate aminotransferase (AST) levels (Peng et al. 2022).